Gluten-Digesting Enzymes
Prolyl endopeptidase · AN-PEP · Aspergillus niger prolyl endoprotease · Prolyl endoprotease
Snapshot
| Indications | Contraindications |
|---|---|
Gluten-digesting enzymes are oral proteases, chiefly Aspergillus niger prolyl endopeptidase (AN-PEP), that cleave proline-rich gluten peptides during digestion. People take them to limit the effects of gluten that slips past a gluten-free diet, mainly celiac disease patients and those with non-celiac gluten sensitivity.
Results are mixed. A 2024 randomized trial in celiac patients on a long-term gluten-free diet found no significant fall in stool gluten peptides, though fewer patients were symptomatic than at run-in. Pretreating gluten with the enzyme avoided fat or carbohydrate malabsorption in most patients who developed it after a gluten challenge2. In non-celiac gluten sensitivity, a randomized trial found no effect on symptoms. In a 2025 simulated-digestion study of pizza, a prolyl-endopeptidase supplement degraded immunotoxic gluten epitopes fastest among three products, yet none abolished the response of celiac-derived T cells; it was a laboratory model, not a clinical trial6. Many products listing gluten-digesting enzymes are sold, often blended with other digestive enzymes; see Form comparison.
The consequential limit is incomplete degradation: some celiac patients still developed malabsorption on enzyme-treated gluten2. United States product labels warn that vitamin K in some formulations may interact with warfarin, a warning on 1 of 21 labels reviewed5.
Last updated October 16, 2026. Read how we make monographs.
In the full monograph
12 sources, 10 studies
- When to useThe situations practitioners use it for, each with the reason and the study behind it.
- SafetyWho should avoid it, who needs extra care, and the side effects reported in studies.
- InteractionsThe medicines and supplements it interacts with, the effect of each, and what labeling says to watch.
- Protocol notesThe doses used in studies, how and when they were taken, and how the forms on the market compare.
- How it worksWhat it is and how it works in the body, in plain terms.
- Published studiesThe studies behind each use, popular claims checked against them, and trials still under way.
- Word of mouthWhat patients and practitioners report online, kept separate from the clinical evidence.
- Clinical perspectiveA closing read of where the evidence is solid, where it is thin, and what has not been studied.
Sources
- 1Effect of Aspergillus niger prolyl endopeptidase in patients with celiac disease on a long-term gluten-free diet.pubmed.ncbi.nlm.nih.govStefanolo, Segura, Grizzuti et al. · World journal of gastroenterology · 2024 · Pubmed
- 2Effect of pretreatment of food gluten with prolyl endopeptidase on gluten-induced malabsorption in celiac sprue.pubmed.ncbi.nlm.nih.govPyle, Paaso, Anderson et al. · Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association · 2005 · Pubmed
- 3Use of a proline-specific endopeptidase to reintroduce gluten in patients with non-coeliac gluten sensitivity: A randomized trial.pubmed.ncbi.nlm.nih.govScricciolo, Lombardo, Elli et al. · Clinical nutrition (Edinburgh, Scotland) · 2022 · Pubmed
- 4A randomised, double-blind, cross-over trial to evaluate bread, in which gluten has been pre-digested by prolyl endoprotease treatment, in subjects self-reporting benefits of adopting a gluten-free or low-gluten diet.pubmed.ncbi.nlm.nih.govRees, Holtrop, Chope et al. · The British journal of nutrition · 2018 · Pubmed
- 5US product labelsdsld.od.nih.govWarnings printed on US dietary supplement labels with this ingredient, from the NIH Office of Dietary Supplements' Dietary Supplement Label Database (DSLD). Manufacturers' precautions, not evidence of harm
- 6Digestion supplemented with commercial proteases: Evaluation of the fate of gluten immunogenic peptides in pizza.pubmed.ncbi.nlm.nih.govCamarca, D'Auria, Rotondi Aufiero et al. · Food research international (Ottawa, Ont.) · 2025 · Pubmed